CompletedNot Applicable

Autofluorescence vs Clinical Assessment of Parathyroid Glands During Thyroid Surgery

Austria, Norway, Poland516 participantsStarted 2021-01-05

Plain-language summary

The purpose of the investigation is to study if the use of Fluobeam®-LX to identify parathyroid glands through autofluorescence during thyroid surgery, may reduce the risk of postoperative hypoparathyroidism, defined as low PTH in patients undergoing total thyroidectomy

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients with thyroid disease planned for total thyroidectomy regardless of diagnosis Exclusion Criteria: * Previous thyroid surgery * Previous parathyroid surgery * Concurrent parathyroid surgery * Renal insufficiency * Pregnancy * Breast feeding * Allergy (contrast agent, iodine) * Inability to understand study information * Patient unable to participate in planned follow-up program

What they're measuring

Postoperative level of Parathyroid hormone (PTH)

Timeframe: First postoperative day

Trial details

NCT IDNCT04509011

SponsorRegion Skane

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-10-01

View on ClinicalTrials.gov More Hypoparathyroidism Postprocedural trials